Literature DB >> 21833043

Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension.

Rong Wu1, Sonia Duchemin, Marc-André Laplante, Jacques De Champlain, Helene Girouard.   

Abstract

BACKGROUND: Inflammation and oxidative stress have been identified as integral parts in the pathogenesis of hypertension. Cyclo-oxygenase-2 which could elicit inflammation and free radicals generation appears to be a key enzyme in hypertension. Cyclo-oxygenase-2 expression and oxidative stress in cardiovascular tissues are increased in the angiotensin II model.
METHODS: Cyclo-oxygenase-1 and cyclo-oxygenase-2 deficient mice and their cultured aortic smooth muscle cells were used to investigate the role of these enzymes in angiotensin II induced superoxide production and hypertension.
RESULTS: At resting state, the superoxide production in aortic and cardiac tissues was lower in cyclo-oxygenase-2 deficient than in the wild type or in cyclo-oxygenase-1 deficient mice. Chronic angiotensin II infusion increased the superoxide production in these tissues from both cyclo-oxygenase-deficient and wild-type mice whereas the level in cyclo-oxygenase-2 deficient mice was equivalent to the basal level in wild-type mice. The hypertensive effect of angiotensin II was attenuated in cyclo-oxygenase-2 deficient mice. Aspirin treatment reduced the basal superoxide production and blunted the oxidative and hypertensive effect of angiotensin II in wild type and cyclo-oxygenase-1 deficient mice whereas it lost completely its antioxidative property in angiotensin II-treated aortic smooth muscle cells isolated from cyclo-oxygenase-2 deficient mice.
CONCLUSIONS: Cyclo-oxygenase-2 pathway plays a major role in the superoxide generation as well as in the angiotensin II-induced oxidative stress and blood pressure. Cyclo-oxygenase-1 activity didn't show any influence on these parameters. These results suggest that cyclo-oxygenase-2 is involved in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833043     DOI: 10.1038/ajh.2011.137

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.

Authors:  Ninitha Asirvatham-Jeyaraj; Andrew J King; Carrie A Northcott; Shivanshu Madan; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

Review 2.  Crosstalk between (Pro)renin receptor and COX-2 in the renal medulla during angiotensin II-induced hypertension.

Authors:  Tianxin Yang
Journal:  Curr Opin Pharmacol       Date:  2015-02-12       Impact factor: 5.547

3.  Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.

Authors:  Fei Wang; Xiaohan Lu; Kexin Peng; Yaomin Du; Shu-Feng Zhou; Aihua Zhang; Tianxin Yang
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

4.  COX-2 mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.

Authors:  Fei Wang; Xiaohan Lu; Kexin Peng; Li Zhou; Chunling Li; Weidong Wang; Xueqing Yu; Donald E Kohan; Shu-Feng Zhu; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-16

5.  Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans.

Authors:  Vincent Pialoux; Marc J Poulin; Brenda R Hemmelgarn; Daniel A Muruve; Erica N Chirico; Camille Faes; Darlene Y Sola; Sofia B Ahmed
Journal:  Front Physiol       Date:  2017-03-10       Impact factor: 4.566

6.  Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.

Authors:  Srinivas Sriramula; Huijing Xia; Ping Xu; Eric Lazartigues
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.